745 related articles for article (PubMed ID: 35819579)
1. Artificial intelligence and machine-learning approaches in structure and ligand-based discovery of drugs affecting central nervous system.
Gautam V; Gaurav A; Masand N; Lee VS; Patil VM
Mol Divers; 2023 Apr; 27(2):959-985. PubMed ID: 35819579
[TBL] [Abstract][Full Text] [Related]
2. Artificial intelligence and machine learning-aided drug discovery in central nervous system diseases: State-of-the-arts and future directions.
Vatansever S; Schlessinger A; Wacker D; Kaniskan HÜ; Jin J; Zhou MM; Zhang B
Med Res Rev; 2021 May; 41(3):1427-1473. PubMed ID: 33295676
[TBL] [Abstract][Full Text] [Related]
3. Recent trends in artificial intelligence-driven identification and development of anti-neurodegenerative therapeutic agents.
Kashyap K; Siddiqi MI
Mol Divers; 2021 Aug; 25(3):1517-1539. PubMed ID: 34282519
[TBL] [Abstract][Full Text] [Related]
4. Artificial intelligence to deep learning: machine intelligence approach for drug discovery.
Gupta R; Srivastava D; Sahu M; Tiwari S; Ambasta RK; Kumar P
Mol Divers; 2021 Aug; 25(3):1315-1360. PubMed ID: 33844136
[TBL] [Abstract][Full Text] [Related]
5. Machine Learning and Artificial Intelligence: A Paradigm Shift in Big Data-Driven Drug Design and Discovery.
Pasrija P; Jha P; Upadhyaya P; Khan MS; Chopra M
Curr Top Med Chem; 2022; 22(20):1692-1727. PubMed ID: 35786336
[TBL] [Abstract][Full Text] [Related]
6. Artificial Intelligence, Machine Learning, and Deep Learning in Real-Life Drug Design Cases.
Muller C; Rabal O; Diaz Gonzalez C
Methods Mol Biol; 2022; 2390():383-407. PubMed ID: 34731478
[TBL] [Abstract][Full Text] [Related]
7. Exploring the artificial intelligence and machine learning models in the context of drug design difficulties and future potential for the pharmaceutical sectors.
Shiammala PN; Duraimutharasan NKB; Vaseeharan B; Alothaim AS; Al-Malki ES; Snekaa B; Safi SZ; Singh SK; Velmurugan D; Selvaraj C
Methods; 2023 Nov; 219():82-94. PubMed ID: 37778659
[TBL] [Abstract][Full Text] [Related]
8. Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery.
Yang X; Wang Y; Byrne R; Schneider G; Yang S
Chem Rev; 2019 Sep; 119(18):10520-10594. PubMed ID: 31294972
[TBL] [Abstract][Full Text] [Related]
9. Machine learning and AI-based approaches for bioactive ligand discovery and GPCR-ligand recognition.
Raschka S; Kaufman B
Methods; 2020 Aug; 180():89-110. PubMed ID: 32645448
[TBL] [Abstract][Full Text] [Related]
10. Artificial Intelligence (AI) in Drugs and Pharmaceuticals.
Sahu A; Mishra J; Kushwaha N
Comb Chem High Throughput Screen; 2022; 25(11):1818-1837. PubMed ID: 34875986
[TBL] [Abstract][Full Text] [Related]
11. Artificial Intelligence and Machine Learning Technology Driven Modern Drug Discovery and Development.
Sarkar C; Das B; Rawat VS; Wahlang JB; Nongpiur A; Tiewsoh I; Lyngdoh NM; Das D; Bidarolli M; Sony HT
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768346
[TBL] [Abstract][Full Text] [Related]
12. Industrializing AI/ML during the end-to-end drug discovery process.
Yoo J; Kim TY; Joung I; Song SO
Curr Opin Struct Biol; 2023 Apr; 79():102528. PubMed ID: 36736243
[TBL] [Abstract][Full Text] [Related]
13. The potential applications of artificial intelligence in drug discovery and development.
Farghali H; Kutinová Canová N; Arora M
Physiol Res; 2021 Dec; 70(Suppl4):S715-S722. PubMed ID: 35199553
[TBL] [Abstract][Full Text] [Related]
14. New avenues in artificial-intelligence-assisted drug discovery.
Cerchia C; Lavecchia A
Drug Discov Today; 2023 Apr; 28(4):103516. PubMed ID: 36736583
[TBL] [Abstract][Full Text] [Related]
15. Evolving scenario of big data and Artificial Intelligence (AI) in drug discovery.
Tripathi MK; Nath A; Singh TP; Ethayathulla AS; Kaur P
Mol Divers; 2021 Aug; 25(3):1439-1460. PubMed ID: 34159484
[TBL] [Abstract][Full Text] [Related]
16. Artificial intelligence in drug discovery: recent advances and future perspectives.
Jiménez-Luna J; Grisoni F; Weskamp N; Schneider G
Expert Opin Drug Discov; 2021 Sep; 16(9):949-959. PubMed ID: 33779453
[No Abstract] [Full Text] [Related]
17. Big Techs and startups in pharmaceutical R&D - A 2020 perspective on artificial intelligence.
Schuhmacher A; Gatto A; Kuss M; Gassmann O; Hinder M
Drug Discov Today; 2021 Oct; 26(10):2226-2231. PubMed ID: 33965571
[TBL] [Abstract][Full Text] [Related]
18. Applications of artificial intelligence to drug design and discovery in the big data era: a comprehensive review.
Tripathi N; Goshisht MK; Sahu SK; Arora C
Mol Divers; 2021 Aug; 25(3):1643-1664. PubMed ID: 34110579
[TBL] [Abstract][Full Text] [Related]
19. Artificial intelligence as an emerging technology in the current care of neurological disorders.
Patel UK; Anwar A; Saleem S; Malik P; Rasul B; Patel K; Yao R; Seshadri A; Yousufuddin M; Arumaithurai K
J Neurol; 2021 May; 268(5):1623-1642. PubMed ID: 31451912
[TBL] [Abstract][Full Text] [Related]
20. Rethinking Drug Repositioning and Development with Artificial Intelligence, Machine Learning, and Omics.
Koromina M; Pandi MT; Patrinos GP
OMICS; 2019 Nov; 23(11):539-548. PubMed ID: 31651216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
